Contribution of metformin therapy with extended release formulas

Authors: Andrej Dukát; Juraj Payer; Milan Kriška; Ján Gajdošík; Fedor Šimko
Authors‘ workplace: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava ¹; Ústav farmakológie a lekárskej farmakológie LF UK v Bratislave ²; Neštátna ambulancia pre dospelých v Nových Zámkoch ³; Ústav patologickej fyziológie LF UK v Bratislave ⁴
Published in: Forum Diab 2021; 10(1): 25-27
Category:

Labels

Diabetology Endocrinology Internal medicine

Osteoporosis in endocrinopathies

Assessment of the osteoporosis risk in patients with type 2 diabetes mellitus – when bone mineral density measurement is not sufficient

Osteoporosis management in diabetic patient

De-intensification of treatment in patient with diabetes mellitus could be beneficial

Population differences in the prevalence of diabetes mellitus, its risk factors and complications

Second generation basal insulin analogues in clinical trials using continuous monitoring of glucose levels

Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports

Diabetic macular oedema treatment with intravitreal dexamethasone: case report

Article was published in

Forum Diabetologicum

2021 Issue 1

Download issue PDF